Literature DB >> 2947883

Dissection of suppressor cell generation in vitro.

G Pawelec, E M Schneider, A Rehbein, I Balko, P Wernet.   

Abstract

Suppressor cells (SC) that nonspecifically inhibited lymphoproliferative (LP) responses were found after culturing peripheral blood mononuclear cells: with suppressor T-cell clones, in mixed lymphocyte cultures (MLC), and with recombinant interleukin 2 (IL-2), but were not found after culture in medium alone. A monoclonal anti-IL-2 receptor (R) antibody (MoAb), TU69, which blocked LP responses of IL 2-dependent T-cell lines, also blocked SC induction by T-cell clones, but completely failed to inhibit SC generation in MLC or with IL-2. This suggests that the IL-2R epitope defined by TU69 was not involved in SC induction in the latter systems. MoAb against HLA-DQ (TU22), -DR (TU34, SG157), -DP (B7/21), or DR and DP (TU43, 58), all of which were able to block stimulation of appropriately specific clones, did not block SC induction in any of the three systems studied. In contrast, the broadly reactive moAb TU39, which binds at least DR and DP but also has additional reactivity for determinants tentatively designated "DY," blocked SC induction by T-cell clones and in MLC. Finally, an anti-HLA class I MoAb, W6/32.HL, greatly decreased SC generation in MLC, but not with rIL-2 or T-cell clones. Thus, the induction of nonspecific SC was dissected into three pathways involving: class I and TU39-defined but not DR, DQ, or DP determinants (in MLC) which was independent of the IL-2R epitope bound by TU69; only TU39-defined determinants (with T-cell clones), which were IL 2R dependent; and, neither class I, class II nor TU39-defined determinants (induction by rIL-2), which was also TU69+ IL-2R independent.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2947883     DOI: 10.1016/0198-8859(86)90285-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  5 in total

1.  Rheumatoid arthritis: autoreactive T cells recognising a novel 68k autoantigen.

Authors:  S Bläss; C Haferkamp; C Specker; M Schwochau; M Schneider; E M Schneider
Journal:  Ann Rheum Dis       Date:  1997-05       Impact factor: 19.103

2.  A novel HLA class II molecule.

Authors:  N Fernandez; M O Labeta; H Festenstein
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  Cellular immunological defects of chronic myelogenous leukaemics: partial dependence on busulphan therapy.

Authors:  G Pawelec; H Schmidt; E Schneider; H J Bühring; G Ehninger
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  CD4+ CD45R- suppressor-inducer T-cell clones: requirements for cellular interaction, proliferation and lymphokines for the induction of suppression in peripheral blood mononuclear cells.

Authors:  G Pawelec
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

5.  DY determinants, possibly associated with novel class II molecules, stimulate autoreactive CD4+ T cells with suppressive activity.

Authors:  G Pawelec; N Fernandez; T Brocker; E M Schneider; H Festenstein; P Wernet
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.